Electroacupuncture use for treatment of taxane-induced peripheral neuropathy in patients with breast cancer: protocol for a pilot, randomised, blinded, sham-controlled trial (EA for CIPN)
Introduction Chemotherapy-induced peripheral neuropathy (CIPN) is a common dose-limiting side effect of neurotoxic chemotherapy. Acute symptoms of CIPN during treatment can lead to dose reduction and cessation. Trials using electroacupuncture (EA) to treat established CIPN postchemotherapy have show...
Main Authors: | Sanjeev Kumar, Susanna B Park, Judith Lacey, Peter Grimison, Gillian Heller, Victoria Choi |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2024-01-01
|
Series: | BMJ Open |
Online Access: | https://bmjopen.bmj.com/content/14/1/e076391.full |
Similar Items
-
The impact of SBF2 on taxane-induced peripheral neuropathy.
by: Geneva M Cunningham, et al.
Published: (2022-01-01) -
Molecular and Cellular Involvement in CIPN
by: Housem Kacem, et al.
Published: (2024-03-01) -
The Future of Chemotherapy: The Mechanisms and Benefits of Exercise in Taxane-Induced Peripheral Neuropathy
by: Sumedha Shastry, et al.
Published: (2023-11-01) -
Electroacupuncture for mild-to-moderate dry eye: study protocol for a multicentre, randomised, single-blind, sham-controlled trial
by: Yue Zhao, et al.
Published: (2023-12-01) -
Electroacupuncture versus sham electroacupuncture in the treatment of postoperative ileus after laparoscopic surgery for colorectal cancer: study protocol for a multicentre, randomised, sham-controlled trial
by: Yu Wang, et al.
Published: (2022-04-01)